WANG Mengying,ZHANG Xinyu,DU Pan,et al.Research progress of anti-tumor effect and mechanism of CDDO and its derivatives[J].ZHONGGUO YAOFANG,2023,34(18):2287-2292.
WANG Mengying,ZHANG Xinyu,DU Pan,et al.Research progress of anti-tumor effect and mechanism of CDDO and its derivatives[J].ZHONGGUO YAOFANG,2023,34(18):2287-2292. DOI: 10.6039/j.issn.1001-0408.2023.18.21.
Research progress of anti-tumor effect and mechanism of CDDO and its derivatives
2-cyano-3,12-dioxooleana-1,9 (11)-dien-28-oic acid (CDDO) is a compound synthesized by taking oleanolic acid, a natural triterpene, as a precursor or precursor, and transforming three modifiable functional groups in the molecule through a series of chemical structure modification. In order to improve its anti-tumor activity, CDDO derivatives are further synth
esized. In this paper, the research results of anti-tumor effects and mechanisms of CDDO and its derivatives in recent years are summarized. It is found that CDDO and its derivatives have a wide range of anti-tumor effects, and can show significant anti-tumor effects on breast cancer, pancreatic cancer, lung cancer and ovarian cancer at low concentrations such as micromole or even nanomole, among which CDDO methyl ester compound (CDDO-Me) and CDDO imidazolidinone compound (CDDO-Im) have the most obvious effects. CDDO and its derivatives exert anti-tumor activity mainly by inducing tumor cell apoptosis, and regulating metabolic reprogramming and immune microenvironment. The involved pathways mainly include Janus protein tyrosine kinase (JAK)/ signal transduction and transcription activation protein 3(STAT3) signal pathway, nuclear factor E2-related factor 2 (NRF2) signal pathway, phosphatidylinositol 3 kinase (PI3K)/protein kinase B (also known as Akt)/mammalian rapamycin target protein (mTOR) signal pathway, Wnt/
β
-catenin signal pathway, nuclear factor κB signal pathway.
关键词
Keywords
references
WANG J L , REN C H , FENG J , et al . Oleanolic acid inhibits mouse spinal cord injury through suppressing inflammation and apoptosis via the blockage of p38 and JNK MAPKs [J ] . Biomedecine Pharmacother , 2020 , 123 : 109752 .
SHANMUGAM M K , DAI X Y , KUMAR A P , et al . Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer:preclinical and clinical evidence [J ] . Cancer Lett , 2014 , 346 ( 2 ): 206 - 216 .
QIN D J , WANG W W , LEI H , et al . CDDO-Me reveals USP7 as a novel target in ovarian cancer cells [J ] . Oncotarget , 2016 , 7 ( 47 ): 77096 - 77109 .
SAMUDIO I , KONOPLEVA M , Jr HAIL N , et al . 2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer [J ] . J Biol Chem , 2005 , 280 ( 43 ): 36273 - 36282 .
JEONG S A , KIM I Y , LEE A R , et al . Ca 2+ influx-mediated dilation of the endoplasmic reticulum and c-FLIPL downregulation trigger CDDO-Me-induced apoptosis in breast cancer cells [J ] . Oncotarget , 2015 , 6 ( 25 ): 21173 - 21192 .
GAO X H , DEEB D , LIU P , et al . Role of reactive oxygen species(ROS)in CDDO-Me-mediated growth inhibition and apoptosis in colorectal cancer cells [J ] . J Exp Ther Oncol , 2011 , 9 ( 2 ): 119 - 127 .
IKEDA T , NAKATA Y , KIMURA F , et al . Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid [J ] . Mol Cancer Ther , 2004 , 3 ( 1 ): 39 - 45 .
WANG X Y , ZHANG X H , PENG L , et al . Bardoxolone methyl(CDDO-Me or RTA402)induces cell cycle arrest,apoptosis and autophagy via PI3K/Akt/mTOR and p38 MAPK/Erk1/2 signaling pathways in K562 cells [J ] . Am J Transl Res , 2017 , 9 ( 10 ): 4652 - 4672 .
SO J Y , LIN J J , WAHLER J , et al . A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regula-ting stem cell signaling pathways in triple-negative breast cancer [J ] . PLoS One , 2014 , 9 ( 9 ): e107616 .
ROGERS L J , JOHN T , PARK J , et al . Growth inhibition and apoptosis of human multiple myeloma cells induced by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid derivatives [J ] . Anticancer Drugs , 2020 , 31 ( 8 ): 806 - 818 .
TSAI T H , LIEU A S , HUANG T Y , et al . Induction of mitosis delay and apoptosis by CDDO-TFEA in gliobla-stoma multiforme [J ] . Front Pharmacol , 2021 , 12 : 756228 .
ALABRAN J L , CHEUK A , LIBY K , et al . Human neuroblastoma cells rapidly enter cell cycle arrest and apoptosis following exposure to C-28 derivatives of the synthetic triterpenoid CDDO [J ] . Cancer Biol Ther , 2008 , 7 ( 5 ): 709 - 717 .
WANG Y Y , YANG Y X , ZHAO R , et al . Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells [J ] . Drug Des Devel Ther , 2015 , 9 : 993 - 1026 .
CASARES L , MORENO R , ALI K X , et al . The synthetic triterpenoids CDDO-TFEA and CDDO-Me,but not CDDO,promote nuclear exclusion of BACH1 impairing its activity [J ] . Redox Biol , 2022 , 51 : 102291 .
JANG H Y , HONG O Y , YOUN H J , et al . CDDO,a PPAR-γ ligand,inhibits TPA-induced cell migration and invasion through a PPAR-γ-independent mechanism [J ] . Oncol Lett , 2022 , 24 ( 4 ): 354 .
SOARES I N , VIANA R , TRELFORD C B , et al . The synthetic oleanane triterpenoid CDDO-Me binds and inhibits pyruvate kinase M2 [J ] . Pharmacol Rep , 2020 , 72 ( 3 ): 631 - 640 .
AKUETTEH P D P , HUANG H M , WU S J , et al . Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5 [J ] . J Biochem Mol Toxicol , 2022 , 36 ( 11 ): e23192 .
ZHAO Y , HUO M R , XU Z H , et al . Nanoparticle deli-very of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma [J ] . Biomate-rials , 2015 , 68 : 54 - 66 .
BALL M S , BHANDARI R , TORRES G M , et al . CDDO-Me alters the tumor microenvironment in estrogen receptor negative breast cancer [J ] . Sci Rep , 2020 , 10 ( 1 ): 656 .
JOHNSON D E , O’KEEFE R A , GRANDIS J R . Targe-ting the IL-6/JAK/STAT3 signalling axis in cancer [J ] . Nat Rev Clin Oncol , 2018 , 15 ( 4 ): 234 - 248 .
DUAN Z F , AMES R Y , RYAN M , et al . CDDO-Me,a synthetic triterpenoid,inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells [J ] . Cancer Chemother Pharmacol , 2009 , 63 ( 4 ): 681 - 689 .
GEE M S , KANG S B , KIM N , et al . Bardoxolone methyl suppresses hepatitis B virus large surface protein variant W4P-related carcinogenesis and hepatocellular carcinoma cell proliferation via the inhibition of signal transducer and activator of transcription 3 signaling [J ] . Pharmaco-logy , 2018 , 102 ( 1/2 ): 105 - 113 .
KHURANA N , CHANDRA P K , KIM H , et al . Bardoxolone-methyl(CDDO-Me)suppresses androgen receptor and its splice-variant AR-V7 and enhances efficacy of enzalutamide in prostate cancer cells [J ] . Antioxidants(Basel) , 2020 , 9 ( 1 ): 68 .
MOERLAND J A , LEAL A S , LOCKWOOD B , et al . The triterpenoid CDDO-methyl ester redirects macrophage polarization and reduces lung tumor burden in a Nrf2- dependent manner [J ] . Antioxidants(Basel) , 2023 , 12 ( 1 ): 116 .
DEEB D , GAO X H , JIANG H , et al . Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR [J ] . Prostate , 2009 , 69 ( 8 ): 851 - 860 .
ZHOU L , WANG Z Y , YU S B , et al . CDDO-Me elicits anti-breast cancer activity by targeting LRP6 and FZD7 receptor complex [J ] . J Pharmacol Exp Ther , 2020 , 373 ( 1 ): 149 - 159 .
SHISHODIA S , SETHI G , KONOPLEVA M , et al . A synthetic triterpenoid,CDDO-Me,inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells [J ] . Clin Cancer Res , 2006 , 12 ( 6 ): 1828 - 1838 .
STADHEIM T A , SUH N , GANJU N , et al . The novel tri-terpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid(CDDO)potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells [J ] . J Biol Chem , 2002 , 277 ( 19 ): 16448 - 16455 .
Research progress on the mechanism of traditional Chinese medicine monomers acting on myelosuppression after chemotherapy based on the four properties theory
Research progress on active components of traditional Chinese medicine inhibiting esophageal carcinoma by targeting mitochondrial apoptosis pathway
Research progress on the action mechanism of monomer components and compound formulations of traditional Chinese medicine in the treatment of vitiligo
Research progress on mechanism of antidepressant action of curcumin
Research progress on the improvement of myocardial fibrosis by traditional Chinese medicine through regulation of NLRP3 inflammasome
Related Author
ZHANG Sihan
WANG Tingting
ZHAO Zhifen
KANG Hanyu
JI Jiaqi
GUO Ziqiang
LIU Tong
JIANG Shiqing
Related Institution
Pediatric Hospital, the First Affiliated Hospital of Henan University of Chinese Medicine
Dept. of Emergency, the First Affiliated Hospital of Henan University of Chinese Medicine
First Clinical Medical College, Henan University of Chinese Medicine
Dept. of Hematology and Oncology, the First Affiliated Hospital of Henan University of Chinese Medicine
Dept. of Oncology, Henan Provincial Hospital of Traditional Chinese Medicine/the Second Affiliated Hospital of Henan University of Chinese Medicine